Doxy-Post-exposure Prophylaxis
Condition(s):Sexually Transmitted DiseasesLast Updated:June 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Sexually Transmitted DiseasesLast Updated:June 9, 2023Recruiting
Condition(s):TuberculosisLast Updated:January 25, 2024Recruiting
Condition(s):Parkinson DiseaseLast Updated:August 8, 2022Recruiting
Condition(s):Post-exposure Prophylaxis; Sexually Transmitted Diseases; DoxycyclineLast Updated:August 23, 2023Not yet recruiting
Condition(s):Neurofibromatosis Type 2Last Updated:October 19, 2023Recruiting
Condition(s):Resectable Pancreatic CancerLast Updated:July 3, 2023Completed
Condition(s):Relapsing Fever, Tick-BorneLast Updated:March 13, 2024Not yet recruiting
Condition(s):Bacterial Sexually Transmitted DiseasesLast Updated:June 28, 2023Recruiting
Condition(s):SyphilisLast Updated:October 31, 2022Recruiting
Condition(s):Lateral Epicondylitis; Lateral Epicondylitis, Left Elbow; Lateral Epicondylitis, Right Elbow; Lateral Epicondylitis, Unspecified Elbow; Lateral Epicondylitis (Tennis Elbow) Bilateral; Medial Epicondylitis; Medial Epicondylitis, Right Elbow; Medial Epicondylitis, Left ElbowLast Updated:December 13, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.